Format

Send to

Choose Destination
Theranostics. 2013 Dec 18;3(12):927-9. doi: 10.7150/thno.8113. eCollection 2013.

MicroRNAs - a new generation molecular targets for treating cellular diseases.

Author information

1
Molecular Imaging Program at Stanford, Bio-X Program, Department of Radiology, Stanford University School of Medicine, Stanford, California, USA.

Abstract

MicroRNAs (miRNAs) are a unique class of non-coding, small RNAs, similar to mRNAs, transcribed by cells, but for entirely different reasons. While mRNAs are transcribed to code for proteins, miRNAs are produced to regulate the production of proteins from mRNAs. miRNAs are central components that tightly and temporally regulating gene expression in cells. Dysregulation of miRNAs expressions in cellular pathogenesis, including cancer, has been reported, and it clearly supports the importance of miRNAs as therapeutic targets in almost every cellular disease. This special issue compiles manuscripts from different authors in order to highlight the importance of microRNAs in cancer and other cellular diseases and how to explore them as therapeutic targets to treat patients with these genetic and metabolic disorders. This issue also covers manuscripts that highlight the obstacles associated with the delivery of therapeutic microRNAs in cells and in vivo in living animals and how to improve and noninvasively monitor the delivery in living animals through molecular imaging, including potential clinical perspectives.

KEYWORDS:

cellular disease; miRNAs; therapeutic targets

PMID:
24396503
PMCID:
PMC3881094
DOI:
10.7150/thno.8113
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Ivyspring International Publisher Icon for PubMed Central
Loading ...
Support Center